0000899243-18-006964.txt : 20180309 0000899243-18-006964.hdr.sgml : 20180309 20180309173022 ACCESSION NUMBER: 0000899243-18-006964 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180307 FILED AS OF DATE: 20180309 DATE AS OF CHANGE: 20180309 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sham Hing CENTRAL INDEX KEY: 0001650158 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37539 FILM NUMBER: 18681270 MAIL ADDRESS: STREET 1: C/O GLOBAL BLOOD THERAPEUTICS, INC. STREET 2: 400 EAST JAMIE COURT, SUITE 101 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Global Blood Therapeutics, Inc. CENTRAL INDEX KEY: 0001629137 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 274825712 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 400 EAST JAMIE COURT, SUITE 101 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650741-7700 MAIL ADDRESS: STREET 1: 400 EAST JAMIE COURT, SUITE 101 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-03-07 0 0001629137 Global Blood Therapeutics, Inc. GBT 0001650158 Sham Hing C/O GLOBAL BLOOD THERAPEUTICS, INC. 171 OYSTER POINT BLVD., SUITE 300 SOUTH SAN FRANCISCO CA 94080 0 1 0 0 See Remarks Common Stock 2018-03-07 4 M 0 10714 0.49 A 98215 D Stock Option (Right to Buy) 0.49 2018-03-07 4 M 0 10714 0.00 D 2024-09-09 Common Stock 10714 10715 D 25% of the shares subject to this option shall vest and become exercisable on July 28, 2015, and the remaining shares subject to this option shall vest and become exercisable in 12 equal quarterly installments thereafter. Senior Vice President, Research Lesley Ann Calhoun, as Attorney-in-Fact 2018-03-09